Saturday 17 October 2026
Export PRFX’s income statement to Excel — free account
PainReform Ltd.
PRFX Healthcare Drug Manufacturers Specialty & Generic
PainReform Ltd.’s revenue for fiscal 2025 (year ended December 2025) was $17,000.00.
0.81
0.04
−4.71%
Follow PRFX
| Older periods | Mar '24 | Jun '24 | Jun '25 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(185.44%) | 0.00% | 0.00% | 0.00% | |
| (126.16%) | 0.00% | 0.00% | 0.00% | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(489.87%) | 0.00% | 0.00% | 0.00% | |
Average Days of Receivables |
— | — | — | — | |
Free Cash Flow per Share |
(754.64) | 0.00 | 0.00 | 0.00 | |
Free Cash Flow |
(12.75) | (15.73) | (15.75) | (13.08) | |
Capital Expenditures |
(0.04) | (0.02) | — | (0.02) | |
| Other line items | |||||
Cash ROIC |
(206.30%) | (2,092.21%) | (131.97%) | (46.66%) | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | — | — | — | |
Research and Development Expense of Revenue |
0.00% | — | — | — | |
Selling, General and Administrative Expense of Revenue |
0.00% | — | — | — | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Operating CF/Net income |
1.28 | 0.00 | 0.00 | 0.00 | |
Depreciation/Fixed assets |
0.46 | 0.50 | 7.65 | 28.48 | |
Capex/Depreciation |
(2.12) | (1.10) | 0.00 | (0.03) | |
Revenue per Share |
0.00 | — | — | — | |
Operating CF per Share |
(752.27) | 0.00 | 0.00 | 0.00 | |
Capex per Share |
(2.37) | 0.00 | — | 0.00 | |
Capex to Sales |
0.00 | 0.00 | — | 0.00 |
Columns are period end dates